Drug Study

BATAAN PENINSULA STATE UNIVERSITY
MAIN CAMPUS
College of Nursing and Midwifery www.bpsu.edu.ph
City of Balanga, 2100 Bataan bpsu.cnm.2018@gmail.com
NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

FREQUENCY RESPONSIBILITIES
Generic Name: Gastric acid-pump  short-term treatment Contraindicated C: Antisecretory
Omeprazole Dosage: Classification: inhibitor: of active duodenal with drug; Proton pump
1-40 mg Proton pump Suppresses gastric ulcer; first-line hypersensitivity to inhibitor
Brand Name: inhibitor acid secretion by therapy in treatment omeprazole or its H: IVTT
Losec (CAN) Route: specific inhibition of heartburn or components; Use E: decrease gastric
Intravenous (IV) of the hydrogen cautiously with acid secretion
symptoms of
potassium ATPase pregnancy, C: Take the drug
gastroesophageal
Frequency: enzyme system at lactation. before meals. Report
Once a day the secretory reflux disease (gerd); severe headache,
surface of the  short-term treatment worsening of
gastric parietal of active benign symptoms, fever,
cells; blocks the gastric ulcer; chills.
final step of acid  gerd, severe erosive K: Swallow the
production. esophagitis, poorly capsules whole; do
responsive not chew, open, or
symptomatic gerd; crush them.
 long-term therapy:
treatment of
pathologic
hypersecretory
conditions.
eradication of h.
pylori with
amoxicillin or
metronidazole and
clarithromycin
MAIN CAMPUS

Blocks pain Mild to moderate HEMA: C: Antisecretory
Generic Name: Dosage: Classification: impulses in CNS, pain or fever Thrombocytopenia, drug; Proton pump
Aspirin 4-80mg Nonnarcotic inhibition of including granulocytotis, inhibitor
analgesic, prostaglandin rheumatoid leukopenia, H: IVTT
Brand Name: Frequency: nonsteroidal anti- synthesis; arthritis, neutropenia, E: decrease gastric
Arthrinol Arthrisin Once a day inflammatory drug antipyretic action osteoarthritis, hemolytic anemia acid secretion
Coryphen (NSAID), results from thromboembolic CNS: Stimulation, C: Take the drug
Easpirin antipyretic, vasodilation of disorders; transient drowsiness, before meals. Report
Ecotrin antiplatelet peripheral vessels; ischemic attacks, dizziness, severe headache,
Emipirin decreases platelet rheumatic fever, confusion, worsening of
Entrophen aggregation. post myocardial convulsion, symptoms, fever,
infarction, flushing, chills.
prophylaxis of MI, hallucinations, K: Swallow the
ischemic stroke, coma capsules whole; do
angina GI: Nausea and not chew, open, or
vomiting, GI crush them.
bleeding, diarrhea,
heartburn, anorexia,
hepatitis
INTEG: Rash,
urticaria, bruising
EENT: Tinnitus,
hearing loss
CV: Rapid pulse,
pulmonary edema
RESP: Wheezing,
hyperpnea
ENDO:
Hypoglycemia,
hyponatremia,
hypokalemia
MAIN CAMPUS
NAME OF DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

DRUG FREQUENCY RESPONSIBILITIES
Generic Name: Dosage: Classification: Inhibits platelet  Treatment of CNS: Headache,  History: Allergy to
Clopidogrel -75mg Therapeutic: aggregation by patients at risk for dizziness, weakness, clopidogrel,
 Adenosine blocking adp
ischemic events-
syncope, flushing
pregnancy, lactation,
Brand Name: Route: diphosphate (ADP) receptors on CV: Hypertension,
Plavix Per Orem (PO) platelets, history of MI, edema bleeding disorders,
receptor antagonist preventing ischemic stroke, recent surgery,
DERMATOLOGIC:
Frequency:  Antiplatelet clumping of peripheral artery Rash, pruritis hepatic impairment,
Once a day platelets. disease GI: Nausea, GI peptic ulcer
Pregnancy distress, GI bleed
Category B Other: Increased
 Provide small,
Treatment of
patients with acute bleeding risk frequent meals if GI
coronary syndrome upset occurs (not as
common as with
aspirin).
 Provide comfort
measures and arrange
for analgesics if
headache occurs.
 Take daily as
prescribed. May be
taken with meals.
MAIN CAMPUS

Generic Name: Dosage: Classification: A low molecular Prevent pulmonary Hemorrhage.  Monitor pregnant women
Enoxaparin 1-0.4ml Anti-coagulants. weight heparin embolism and deep Thrombocytopenia using the drug.
Anti thrombotics derivative that vein thrombosis Increase Liver
Brand Name: Route: accelerates after hip or knee Enzymes  Instruct patient and family
Lovenox Subcutaneous (SC) formation of anti - replacement Exceptional Case of to watch for signs of
thrombin III- surgery, abdominal Skin Necrosis bleeding or abnormal
thrombin complex surgery ad patients Rarely cutaneous or bruising.
and deactivates with acute illness systemic allergic  Tell patient to avoid OTC
thrombin, who are at reaction
preventing increased risk of drugs containing aspirin
conversion of decreased mobility or other salicylates unless
fibrinogen to fibrin. ordered by physician.
MAIN CAMPUS

Losartan Potassium Inhibits Hypentension CNS dizinnes Monitor Patients BP
Dosage vasoconstrictive and nephpatically in type 2 asthenia fatigue Monitor patients who
Brand Name aldosterone secreting diabetic patient to headache insomnia are also taking
Cosaar 180 mg tab action of angiotensin reduce risk of CVA in diuretics for
Frequency II resepetor on the patients with symptomatic
Once a day surface of vascular hypertensions and left hypotension
smooth muscle and ventricularhypertrophy Assess patients renal
other tissue cell function
MAIN CAMPUS

Atorvastatin Calcium Channel Atorvastatin is Treatment of mid to  Palpations Monitor Patients BP
Dosage Blocker calcium channel moderate For therapeutic
 Flushing tachy
Brand Name blocking agent that hypertension and effectiveness BP
cardia
Amlodipine 80 mg tab selectively bloks aginia reduction is greatest
Frequency calcium ion reflux
 Peripheral or after peak levels of
Once a day across cell facial edema atorvastatin are
membrane of cardiac  Bradycardia achieved 6-9 h
and vascular smooth  Chest paint following oral doses
muscle without
 Synope
changing serum
 Postural
calcium
concentration it hypertension
predominantly acts
on peripheral
circulation
decreasing
peripheral vascular
resistance and
increase cardiac
output
MAIN CAMPUS
MAIN CAMPUS

Diltiazem Calcium Channel Diltiazem is in the Treatment of mid to  Dizziness Monitor Patients BP
Dosage Blocker group of drugs called moderate fainting fast or For therapeutic
Brand Name calcium channel hypertension and effectiveness BP
pound heart
Amlodipine 30 mg tab blockers. It works be aginia( chest pain ) reduction is greatest
beat
Frequency relaxing the muscles after peak levels of
TID of your heart and Certain heart rhythm  Upper atorvastatin are
blood vessels disorders stomach pain achieved 6-9 h
Diltiazem is a potent itching following oral doses
vasodilator
 Flushing (
increasing blood
warmth
flow and variably
decreasing the heart
redness or
rate via strong (tingly feeling)

depression of A-V
node conduction
MAIN CAMPUS

Budesonide Budesonide is an anti- budesonide inhalation  Nausea  History: Untreated
local nasal
Dosage belongs to a class inflammatory suspension) is vomiting
infections, nasal
Brand Name Neb of medications corticosteroid that indicated for the diarrhea trauma, septal
ulcers, recent
BUDESONIDE Q 12o called exhibits potent maintenance stomach pain
nasal surgery,
corticosteroids. It glucocorticoid treatment of asthma  Head ache lactation
 Physical: BP, P,
works by activity and weak and as prophylactic  Runny or stuffy auscultation; R,
decreasing mineralocorticoid therapy nose adventitious
sounds;
swelling and activity. ... The  Sneezing examination of
irritation in the activity of nares
airways to allow for RHINOCORT
easier breathing. AQUA Nasal
Spray is due to the
parent drug,
MAIN CAMPUS
NAME OF DRUG DOSAGE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

ROUTE RESPONSIBILITIES
FREQUENCY
glyxambi GLYXAMBI combines 2 GLYXAMBI is a   GLYXAMBI is not
recommended for
Brand Name Dosage tablets contain two antihyperglycemic agents combination of  Hypersensitivity patients with type
empagliflozin and oral with empagliflozin  Severe renal 1 diabetes or for
impairment (eGFR the treatment
linaglipt 25 mg tab antihyperglycemic complementary mechanisms and linagliptin
of diabetic
Frequency drugs used in the of action to improve indicated as an <30 mL/min/1.73 ketoacidosis
m2/end-stage renal 
OD am management of glycemic control in patients adjunct to diet
disease/dialysis)
type 2 diabetes: with type 2 diabetes: and exercise to
 Type 1 diabetes;
empagliflozin and empagliflozin, a sodium- improve
 Diabetic
linaglipti glucose co-transporter 2 glycemic control
ketoacidosis;
(SGLT2) inhibitor, and in adults with  Lactation: Avoid
linagliptin, a dipeptidyl type 2 diabetes use, discontinue
peptidase-4 (DPP-4) inhibitor. mellitus when breastfeeding or
treatment with discontinue
both empagliflozin;
empagliflozin
and linagliptin is
appropriate.
MAIN CAMPUS
SOAPIE
Subjective Objective Assessment Planning Interventions Evaluation
 Generalized Activity In Short Term: Independent Short term
After 8hrs of nursing  Assess patient general After 8 hrs. of nursing
Madalas akong weakness tolerance related intervensions
condition interventions the
hingalin kaya to imbalance of
 Limited range of   Discontinue activities objectives are partially
madalas hindi oxygen supply Patients states desire to
met
ako gaanong motion as and demand increase activity level that cause undesired
observed  Patients States psychological changes
nakakakilos Patient stated
understanding of the  Encourage patient to
 Tachypneic with need to increase activity
understanding of the
have adequate bed need to perform daily
As verbalized by RR of 28 level Gradually rest and sleep activities
the patient  Blood Pressure and
 Rapid and  Provide the client a
pulse respiratory rates
irregular clam and quiet
remains within
environment
heartbeat with prescribed limits during
activity  Note presence of
the PR of 110  Patients demonstrate factors that can
bpm skill in conserving energy contribute to fatigue
while carrying out daily  Encourage the patient
 Oxygen
activities to tolerance to maintain positive
Saturation 93% level attitude
 Patient states
satisfaction with each Dependent
new level of activity  Administer
attained supplemental oxygen
as indicated
MAIN CAMPUS

Drug Study

Transféré par

Informations du document

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

Drug Study

Transféré par

Droits d'auteur :

Formats disponibles

BATAAN PENINSULA STATE UNIVERSITY

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

rate via strong (tingly feeling)

NAME OF DRUG DOSAGE ROUTE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

NAME OF DRUG DOSAGE CLASSIFICATION MECHANISM INDICATIONS CONTRADICTION NURSING

Vous aimerez peut-être aussi